Multiple Endocrine Neoplasia Type 2 Sequencing

Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant disorder classified into three subtypes: MEN2A, FMTC (familial medullary thyroid carcinoma), and MEN2B. All three subtypes carry a high risk for development of medullary carcinoma of the thyroid (MTC). RET is the only gene known to be associated with MEN type 2.

Chromosome locus 10q11.2

Methodology: Sequencing of entire coding region

Purpose: Confirmation of Clinical Diagnosis/Carrier Testing

Test Requisition: Sequencing Requisition

CPT Code: 81405 Cost: $978.00

Turn-around-time: 3-4 weeks